<--- Back to Details
First PageDocument Content
Business / Economy / Pharmaceutical industry / S&P/TSX 60 Index / S&P/TSX Composite Index / Valeant Pharmaceuticals / Allergan /  Plc / Teva Pharmaceutical Industries / Actavis / Mylan / KP / Perrigo
Business
Economy
Pharmaceutical industry
S&P/TSX 60 Index
S&P/TSX Composite Index
Valeant Pharmaceuticals
Allergan
Plc
Teva Pharmaceutical Industries
Actavis
Mylan
KP
Perrigo

Microsoft PowerPoint - Kurmann Partners - An Overview on M&A in the Pharmaceutical industry - CPhI pre-Connect October.

Add to Reading List

Source URL: www.kurmannpartners.com

Download Document from Source Website

File Size: 1,33 MB

Share Document on Facebook

Similar Documents

January 8, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

DocID: 1rlhw - View Document

December 4, 2015  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Teva, Takeda Form Generics Joint Venture in Japan Teva Pharmaceu

December 4, 2015 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Teva, Takeda Form Generics Joint Venture in Japan Teva Pharmaceu

DocID: 1qVa0 - View Document

Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016

Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016

DocID: 1qPF6 - View Document

LEGAL NOTICE and TERMS OF USE Teva Respiratory, LLC (“Teva Respiratory”) maintains the sites www.ProAirHFA.com and www.MyProAir.com, and www.ProAir.com (the

LEGAL NOTICE and TERMS OF USE Teva Respiratory, LLC (“Teva Respiratory”) maintains the sites www.ProAirHFA.com and www.MyProAir.com, and www.ProAir.com (the "sites") for your personal information, education, and comm

DocID: 1qLFt - View Document

Statement of the Federal Trade Commission In the Matter of Teva Pharmaceuticals Industries Ltd. and Allergan plc

Statement of the Federal Trade Commission In the Matter of Teva Pharmaceuticals Industries Ltd. and Allergan plc

DocID: 1q2DC - View Document